Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma
Clinical trial NCT05665725 · COMPLETED
Trial details
- NCT number
- NCT05665725
- Sponsor
- Timothy Voorhees
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-31
- Primary completion
- 2023-09-27
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.